ALDH+/CD133+ subpopulations of colorectal cancer cells have been reported as having an increased ability to generate tumour xenografts compared with ALDH+/CD133– or ALDH+ alone, and exhibits properties of colorectal cancer stem cells in vitro and in vivo (Huang et al, 2009). The gene discussed is PROM1; the disease is colorectal cancer.